Namdev Dhas
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 29
- Graphene and Nanomaterials Applications 14
- Biomaterials 30
- Nanoparticle-Based Drug Delivery 26
- Co-authors
- Ritu Kudarha (27 shared papers)Tejal Mehta (20 shared papers)Srinivas Mutalik (34 shared papers)Abhijeet Pandey (11 shared papers)Pradum Pundlikrao Ige (2 shared papers)Ajinkya Nitin Nikam (5 shared papers)Sanjay Kulkarni (10 shared papers)Soji Soman (9 shared papers)
- Journals
- Journal of Controlled Release (6 papers)International Journal of Pharmaceutics (5 papers)Journal of Drug Delivery Science and Technology (4 papers)OpenNano (3 papers)Coordination Chemistry Reviews (3 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Namdev Dhas
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 237
- Biomaterials 475
- Biomedical Engineering 633
- Molecular Medicine 60
- Inorganic Chemistry 112
Countries citing papers authored by Namdev Dhas
This map shows the geographic impact of Namdev Dhas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Namdev Dhas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Namdev Dhas more than expected).
Fields of papers citing papers by Namdev Dhas
This network shows the impact of papers produced by Namdev Dhas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Namdev Dhas. The network helps show where Namdev Dhas may publish in the future.
Co-authors
The 25 scholars most cited alongside Namdev Dhas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 127 | |
| 2 | 2015 | 100 | |
| 3 | 2022 | 85 | |
| 4 | 2020 | 65 | |
| 5 | 2023 | 58 | |
| 6 | 2022 | 57 | |
| 7 | 2022 | 51 | |
| 8 | 2020 | 50 | |
| 9 | 2023 | 46 | |
| 10 | 2021 | 41 | |
| 11 | 2021 | 40 | |
| 12 | 2020 | 40 | |
| 13 | 2021 | 37 | |
| 14 | 2014 | 35 | |
| 15 | 2019 | 31 | |
| 16 | 2023 | 28 | |
| 17 | 2022 | 28 | |
| 18 | 2024 | 27 | |
| 19 | 2025 | 26 | |
| 20 | 2024 | 26 |
About Namdev Dhas
Namdev Dhas is a scholar working on Biomedical Engineering, Biomaterials, Molecular Biology, Pharmaceutical Science and Materials Chemistry, having authored 87 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (29 papers), Nanoparticle-Based Drug Delivery (26 papers), Advanced Drug Delivery Systems (17 papers), Graphene and Nanomaterials Applications (14 papers), Advanced biosensing and bioanalysis techniques (8 papers), RNA Interference and Gene Delivery (7 papers), Advancements in Transdermal Drug Delivery (5 papers) and Drug Solubulity and Delivery Systems (4 papers). The work is most often cited by research in Pharmaceutical Science (237 citations), Biomaterials (475 citations), Biomedical Engineering (633 citations), Molecular Medicine (60 citations) and Inorganic Chemistry (112 citations). Namdev Dhas has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Ritu Kudarha, Tejal Mehta, Srinivas Mutalik, Abhijeet Pandey, Pradum Pundlikrao Ige, Ajinkya Nitin Nikam, Sanjay Kulkarni, Soji Soman, Mónica Cristina García and Atul Garkal. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, OpenNano and Coordination Chemistry Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.